Market Overview

Alnylam Pharma Reports Offering of $125M in Stock

Related ALNY
Events Scheduled for Week of Jun 23rd to Jun 27th, 2014
Alnylam-TAP Collaborate for AAT Candidate - Analyst Blog

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leading RNAi therapeutics company, today announced that it has commenced an underwritten public offering of shares of its common stock to raise aggregate proceeds of approximately $125 million. All of the shares in the offering are to be sold by Alnylam.

Posted-In: News Offerings

 

Most Popular

Related Articles (ALNY)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free